Health Care’s Silent Spring
As the Intergovernmental Working Group (IGWG) of the WHO prepares to meet and discuss how to best facilitate the expropriation of intellectual property rights (in this case the IPR of pharmaceutical...
View ArticleMumie – Description and Origin
Though Mumie has been used in folk medicine of different countries for almost two thousand years, there are still many legends regarding its mysterious origin. In Russia serious research has been...
View ArticleBeijing Genomics Institute signs global site license with CLC bio for Next...
Aarhus Denmark, July 3rd, 2008 – Beijing Genomics Institute (BGI) has signed a global site license agreement for CLC bio’s Next Generation Sequencing solution, CLC Genomics Workbench. The site...
View ArticleSeegene and Shimadzu Agree to Join Multi-Pathogen Tests and Platform for...
ROCKVILLE, MD and KYOTO, JAPAN–July 28, 2008 – Seegene, Inc. and Shimadzu Corporation today announced a strategic partnership to combine Seegene’s Seeplex(R) multi-pathogen tests with Shimadzu’s...
View ArticleAstraZeneca, Singapore institutions sign innovative new partnership to...
Healthcare company AstraZeneca Plc (AZN: News, Chart, Quote ,AZN.L: News, Chart, Quote ) said Friday that it signed an innovative new partnership with the National Cancer Centre Singapore, or NCCS, and...
View ArticleFirst of 100 Arab Human Genomes Sequenced by Saudi Biosciences, Beijing...
Riyadh, Kingdom of Saudi Arabia — September 9, 2008 — An international consortium consisting of Saudi Biosciences, Beijing Genomics Institute Shenzhen, and CLC bio have in a joint effort performed an...
View ArticleSeegene Receives Approval from Health Canada for Its Respiratory Virus...
Seegene Receives Approval from Health Canada for Its Respiratory Virus Multi-Pathogen Detection Tests Seeplex(R) RV5 and RV12 give Canadian caregivers an effective way to test for a broad range of...
View ArticleClinical Trials in Asia Summit 2009
Determining the prospective strategies for Implementing Clinical trials in India & South Asia – Today’s Hottest Market 18th – 20th May 2009, The Park, New Delhi, India  Key Speakers •...
View ArticleRanbaxy to transfer drug discovery unit to Daiichi Sankyo
Jul 06, 2010 (Datamonitor via COMTEX) – Daiichi Sankyo and Ranbaxy Laboratories, a research based pharmaceutical company, have announced that Ranbaxy’s new drug discovery research, or NDDR, has been...
View ArticleChemie Uzbekistan 2011
The 5th Anniversary Central Asian International exhibition «Chemical industry – Chemie Uzbekistan» and the 2nd Uzbek International exhibition of plastics and rubber – «Plastex Uzbekistan 2011» will be...
View ArticleAncient Chinese cures translate into modern Western medicines
The Chem-TCM is the most comprehensive database of its kind and translates more than 12,000 chemicals from more than 300 Chinese herbs used in traditional Chinese medicine (TCM) into Western...
View ArticleChina diabetics raise stakes for healthcare reform
BEIJING – In 30 years, the Chinese people have gone from having barely enough to eat to worrying about spreading waistlines, leaving the healthcare system struggling to keep up with an exponential rise...
View ArticleA New Herbal Formula has Been Invented to Treat Chronic Prostatitis
State Intellectual Property Office of the P.R.C (SIPO) has recently published a patent of herbal formula for treating prostatitis. New herbal medicine Diuretic and Anti-inflammatory Pill invented by...
View ArticleSoutheast Asian TCM brand Eu Yan Sang Speeds up Expansion in China
Eu Yan Sang International, an established traditional Chinese medicine (TCM) brand that started in Southeast Asia, is speeding up its expansion on the Chinese mainland after three years of efforts to...
View ArticleToxins found in traditional Chinese medicine
A host of potential toxins, allergens and traces of endangered animals showed up in DNA sequencing tests on 15 Chinese traditional medicines, researchers said on Thursday. Such therapies have been used...
View ArticleBiotie Regains Asia-Pacific Rights for VAP-1 Antibody Program from Seikagaku
Biotie Therapies and Seikagaku have agreed to terminate their license agreement for Biotie’s VAP-1 antibody program, BTT-1023. The decision also nixes Seikagaky’s option for Biotie’s VAP-1 SSAO small...
View ArticleSanten Nabs Japanese Co-Promotion Rights to Bayer and Regeneron’s Eylea
Santen Pharmaceuticals negotiated co-promotion rights to Regeneron Pharmaceuticals and Bayer HealthCare’s Eylea® (aflibercept; VEGF Trap-Eye) injection in Japan. Bayer’s Japanese subsidiary Bayer...
View ArticleSource BioScience, DNAFORM to Offer Japanese Version of DNA Clone, Antibody...
Source BioScience and DNAFORM are launching the Japanese version of Source BioScience’s GenomeCube® database and webstore. GenomeCube provides access to a portfolio of 20 million DNA clones and...
View ArticleGE Healthcare, BGI Explore Stem Cell Genetics with a View to Drug Discovery...
GE Healthcare and China-based sequencing firm BGI signed a multiyear stem cell science collaboration that aims to provide new insights into the genetic variation of ethinically diverse human stem cell...
View ArticleMerck Steps Further into HIV Space
Merck & Co. expanded its reach into the HIV arena by signing two licensing agreements for investigational drug candidates. One deal is with Chimerix, based in Research Triangle Park, NC, and the...
View Article
More Pages to Explore .....